🇺🇸 FDA
Patent

US 7713526

Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

granted A61KA61K2039/505A61P

Quick answer

US patent 7713526 (Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas) held by The Regents of the University of California expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P35/02